Shaping the Future of Global Biotech, Powered by Asia (The Largest Corporate Access Event Between Asia and Western Biopharma Industry)
This is the global stage where Asia’s most innovative biotechs meet Western pharma, investors, and BD leaders. ACCESS ASIA bridges deal-making, licensing, investment, and collaboration between two of the most dynamic markets in biopharma today.
-
For Investors: Gain direct access to Asia’s cutting-edge biotech pipelines and upcoming licensing opportunities.
- For Pharma & BD Leaders: Identify strong Asia-based partners and accelerate your global portfolio strategy.
- For Innovators: Showcase your science and business to the world’s most influential investors and pharma executives.
From JPM to deal closing: we don’t just offer presentations — we offer much more.
Presenters receive a full-service package, enabling engagement with global partners, in-depth BD discussions, and 1x1 meetings with hundreds of registrants.
100 Innovators to Watch Digital Booklet
We are excited to launch the ACCESS ASIA: 100 Innovators to Watch Digital Booklet.
- Version 1 will be released in October 2025.
-
Distributed globally to BD executives, investors, and pharma leaders. -
Features top biotech innovators from across Asia.
👉Complimentary Access: Registrants looking for assets to in-license will be granted free access to review the Asia 100 Innovators to Watch and request pre-scheduled 1x1 meetings during the forum.
Secure your place, APPLY HERE: https://assets.yafocapital.com/#/assets/apply
- 200+ global attendees expected
- 20 company presentations, 7 keynotes, 2 panel discussions (MNC, VC, biotechs, pharma)
- Pre-scheduled biotech & pharma 1x1 meetings with ACCESS ASIA-100 assets
Secure your spot and access the heart of cross-border biotech partnering:
👉https://biotochina.org/register/
✔ Interested in Sponsoring? Contact Wendi Xiang:
WeChat: (+86) 137-3368-5995
Email: wxiang@yafocapital.com
Over the years, ACCESS Asia has brought together leading companies, investors, and executives shaping the future of biotech.
Whether you’re an investor, pharma BD leader, or Asian biotech innovator, ACCESS Asia @ JPM 2026 is your opportunity to turn introductions into deals and insights into strategy.
See you in San Francisco.